检索结果 - Lucile Awad
- Showing 1 - 4 results of 4
-
1
Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials 由 Emmanuel Mitry, Jean‐Yves Douillard, Eric Van Cutsem, David Cunningham, E. Magherini, D. Méry-Mignard, Lucile Awad, P. Rougier
出版 2004Revisão -
2
-
3
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after... 由 Gilles Freyer, P Rougier, R. Bugat, J‐P Droz, Marion Marty, Harry Bleiberg, D. Mignard, Lucile Awad, Patrice Herait, Stéphane Culine, V. Trillet-Lenoir
出版 2000Artigo -
4
Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcino... 由 Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla, C. Boni, Adriano Rodrigues, M Fodor, Yee Chao, Э К Возный, Lucile Awad, Eric Van Cutsem
出版 2007Artigo
相关主题
Cancer
Internal medicine
Medicine
Chemotherapy
Colorectal cancer
Gastroenterology
Irinotecan
Oncology
Fluorouracil
Performance status
Surgery
Adenocarcinoma
Cisplatin
Clinical endpoint
Clinical trial
Confidence interval
Docetaxel
Hazard ratio
Multivariate analysis
Neutropenia
Nursing
Phases of clinical research
Progression-free survival
Quality of life (healthcare)
Toxicity
Univariate analysis